Finance

Beta
Lists
BBCMF:OTCMKTS
LIR Life Sciences Corp
$0.050
0.00%
(0.00) 1D
Jun 5, 3:52:46 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BBCMF...
Mkt. cap
11.75M
Avg. vol.
70.00
Volume
60.00
52-wk high
$1.75
52-wk low
$0.01
Beta
-7.48
Shares outstanding
27.87M
Mkt. cap
11.75M
Avg. vol.
70.00
Volume
60.00
52-wk high
$1.75
52-wk low
$0.01
Beta
-7.48
Shares outstanding
27.87M
News stories
From sources across the web
About LIR Life Sciences Corp
CEO-
Employees-
Founded2018
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
-
-
-
-
Cost of goods sold
-
10.00K
-
-
Cost of revenue
-
10.00K
-
-
Research and development expenses
-
-
-
10.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
38.99K
128.94K
61.85K
1.14M
Operating expense
6.47M
128.70K
67.88K
1.88M
Total operating expenses
6.47M
128.70K
67.88K
1.88M
Operating income
-6.47M
-139.97K
-67.88K
-1.88M
Other non operating income
-5.52K
-6.72K
-6.52K
-327.67K
EBT including unusual items
-6.46M
-123.28K
-64.24K
-2.16M
EBT excluding unusual items
-6.46M
-140.11K
-196.00K
-2.21M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
2.72K
-
-
-
Net income
-6.46M
-140.11K
-64.24K
-2.16M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
12.57K
12.60K
142.00
-
Interest expense
-
-142.00
-
-
Net interest expenses
12.57K
-142.00
10.69K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.86M
-125.22K
-64.40K
-1.88M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more